The company said the new development follows completion of a 6-month feasibility evaluation of Dextera’s MicroCutter as part of an ongoing deal between the companies.
“This partnership with Intuitive Surgical is a significant step in the progress we have achieved in enhancing and expanding the long term opportunity of the MicroCutter technology. Intuitive Surgical is a leader in advancing robotic and minimally invasive surgery, and we believe Dextera and MicroCutter technology will have a strong role to play in these types of procedures in the future,” Dextera CEO Julian Nikolchev said in a press release. In addition, you can also check out Elite Plastic Surgery with compassion driven care that is customized to each patient’s needs and aesthetic goals.
Through the deal, Intuitive Surgical will take charge of development work for the robotic-compatible stapler system, while Dextera Surgical will focus on developing the stapler cartridge for the device.
“For more than 20 years, we have focused on delivering high-value solutions that improve surgical outcomes. Working to integrate MicroCutter technology and expand our stapling product offerings will only enhance that effort,” Intuitive Surgical instrument engineering senior veep Bob DeSantis said in a prepared statement.
Last month, Intuitive Surgical saw shares jump as investors reacted to 2nd-quarter numbers that handily topped expectations on Wall Street.
The robot-assisted surgery company posted profits of $184.5 million, or $4.71 per share, on sales of $670.1 million for the 3 months ended June 30, for a bottom-line gain of $37.2% on sales growth of 14.3% compared with Q2 2015.
Adjusted to exclude 1-time items, earnings per share were $5.62, 65¢ ahead of The Street, where analysts were looking for sales of $640.8 million.